台灣泌尿科醫學會E-School

台灣泌尿科醫學會E-School

Perioperative Durvalumab with Neoadjuvant Chemotherapy in MIBC_Tae-Hwan Kim

03-14 • 觀看: 10 • 回應: 0 • embed
EV302 Unveiled: Revolutionize the Future of 1L LA/mUC Treatemnt_Ignacio Durán

03-14 • 觀看: 12 • 回應: 0 • embed
Treatment Intensification in Metastatic Hormone-Sensitive Prostate Cancer & Real-World Experience of Using Generic Abiraterone_Pongwut Danchaivijitr

03-14 • 觀看: 13 • 回應: 0 • embed
Digital Pathology with Prostate Cancer_Hong Koo Ha

03-14 • 觀看: 13 • 回應: 0 • embed
Emerging Roles of PSMA Based Diagnostics and Therapeutics in Prostate Cancer_Raj Tiwari

03-14 • 觀看: 22 • 回應: 0 • embed
Unveiling EV+P's potential: EV-302 Asian Subgroup and Real-World Outcome in CGMH-KH_劉惠瑛

03-14 • 觀看: 16 • 回應: 0 • embed
A New Era in La/mUC: How EV302 Transforms First-Line Therapy for Urothelial Cancer_Ignacio Durán

03-14 • 觀看: 25 • 回應: 0 • embed
Surgical Management of NLUTD in Chronic SCI Patients_范玉華

02-19 • 觀看: 8 • 回應: 0 • embed
Urinary diversion and urinary tract reconstruction – augmentation, ileal interposition, neobladder urodynamics_郭漢崇

02-19 • 觀看: 2 • 回應: 0 • embed
Pharmacological Treatment of NLUTD in Chronic SCI Patients_陳聖復

02-19 • 觀看: 8 • 回應: 0 • embed
Nocturia and nocturnal polyuria – evaluation, diagnosis, and appropriate management_郭漢崇

02-19 • 觀看: 3 • 回應: 0 • embed
Videourodynamic study interpretation of LUTD and selecting appropriate medications based on VUDS findings_郭漢崇

02-19 • 觀看: 2 • 回應: 0 • embed

Prev
10
11
12
13
14
15
16
17
18
19
Next
/ 1052